Retrospective Study
Copyright ©The Author(s) 2025.
World J Clin Cases. Jul 26, 2025; 13(21): 103841
Published online Jul 26, 2025. doi: 10.12998/wjcc.v13.i21.103841
Figure 2
Figure 2 Survival estimate between microcystic, elongated, and fragmented group and non- microcystic, elongated, and fragmented group. There was significant difference in progression-free survival between microcystic, elongated, and fragmented (MELF) group and non-MELF group by Kaplan-Meier analysis (P < 0.05). MELF: Microcystic, elongated, and fragmented.